13G Filing: Sabby Capital and Taxus Cardium Pharmaceuticals Group Inc. (CRXM)

(ii)
Shared power to vote or to direct the vote
1,435,917
,(iii)
Sole power to dispose or to direct the disposition of
0
,(iv)
Shared power to dispose or to direct the disposition of
1,435,917
.As calculated in accordance with Rule 13d-3 of the Securities Exchange
Act of 1934, as amended, (i) Sabby Healthcare Master Fund,
Ltd. beneficially owns 1,435,917 shares of the Issuer’s common stock
(Common Stock), representing approximately 9.99% of the Common Stock,
and (ii) Sabby Management, LLC and Hal Mintz each beneficially own
1,435,917 shares of the Common Stock, representing approximately 9.99% of
the Common Stock. Sabby Management, LLC and Hal Mintz do not directly own
any shares of Common Stock, but each indirectly owns 1,435,917 shares of
Common Stock. Sabby Management, LLC, a Delaware limited liability company,
indirectly owns 1,435,917 shares of Common Stock because it serves as the
investment manager of Sabby Healthcare Master Fund, Ltd. Mr.
Mintz indirectly owns 1,435,917 shares of Common Stock in his capacity
as manager of Sabby Management, LLC.